GV Investment Managers

GV Investment Managers is a private equity firm founded in 2000 and based in Stamford, Connecticut. The firm specializes in impact investing, private equity, and portfolio management services. It focuses on sectors such as life sciences, consumer products, enterprise solutions, cryptocurrency, climate technology, and frontier innovations. With Alphabet as its sole limited partner, GV Investment Managers primarily targets investments in North America and Europe. The firm collaborates with operating partners who assist startups in areas such as design, diversity and inclusion, talent acquisition, and engineering, while also facilitating connections with Google for technological support and expertise.

Brian Bendett

Partner

Brendan Bulik-Sullivan

General Partner

Terri Burns

Partner

Frederique Dame

Partner

Karim Faris

General Partner

Crystal Huang

Partner

Tom Hulme

General Partner and Head of Europe

John Lyman

Partner

Laura Melahn

Partner

Erik Nordlander

General Partner

David Reshef

Venture Partner

Ben Robbins

General Partner

Issi Rozen

Venture Partner

M.G. Siegler

General Partner

Andy Wheeler

General Partner

Krishna Yeshwant

Managing Partner

Sangeen Zeb

Partner

David Schenkein

General Partner

Past deals in Series C

Infinitus Systems

Series C in 2024
Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.

Harvey

Series C in 2024
Harvey is an artificial intelligence technology service provider for knowledge workers. It uses AI to answer legal questions and lands cash from OpenAI. The product provides lawyers with a natural language interface for their existing legal workflow. It offers a unified and intuitive interface for all legal workflows, allowing lawyers to describe tasks in plain English instead of using a suite of complex and specialized tools for niche tasks. Harvey was founded in 2022 and is based in Washington, DC.

StrongDM

Series C in 2024
StrongDM helps organizations manage and secure access to critical infrastructure by using a zero-trust approach. The platform provides users with controlled access to databases, servers, and applications, while also giving administrators clear visibility and audit trails.

Ripcord

Venture Round in 2024
Ripcord, Inc. is a robotic digitization company founded in 2014 and headquartered in Los Angeles, California. The company specializes in creating a platform for paperless document management, utilizing advanced technologies such as artificial intelligence, machine learning, and vision-guided robotics. Their primary product, Canopy, employs automation software to capture, enrich, and organize essential content, effectively creating a digital twin of information. By integrating sensors and software automation, Ripcord enables enterprises to enhance their business processes, improving speed, quality, and accuracy in managing important documents. The company, originally known as Ripcord Digital, Inc., rebranded in June 2017 to reflect its focus on innovative digitization solutions.

Accent Therapeutics

Series C in 2024
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.

Lightmatter

Series C in 2023
Lightmatter specializes in developing photonic chips that leverage light for data processing and communication, significantly enhancing the speed and efficiency of artificial intelligence computations. By utilizing integrated optical technology, the company designs processors that accelerate key operations in neural networks through programmable photonic elements, which are fabricated alongside traditional transistors. This innovative approach allows for improved performance in applications such as image recognition and natural language processing while maintaining low power consumption. Lightmatter's technology primarily serves sectors including artificial intelligence, cloud computing, and telecommunications, positioning the company as a leader in light-based computing solutions.

Nothing

Series C in 2023
Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data

Series C in 2023
Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

Synthesia

Series C in 2023
Synthesia Ltd. is a London-based company that specializes in an artificial intelligence-driven video production platform. Founded in 2017, the company offers a service that transforms text into professional-quality videos featuring customizable avatars and voiceovers in over 140 languages. Its innovative video synthesis technology allows users to create high-end videos for various applications, including personalized advertising, corporate communications, e-learning, and marketing. By synchronizing lip movements with new dialogue tracks, the platform facilitates the translation of video content into different languages, thereby enhancing distribution channels. Users can quickly create, edit, and share studio-quality videos directly in their browser, utilizing fully cloneable AI video templates to streamline production and meet diverse content needs.

Lightmatter

Series C in 2023
Lightmatter specializes in developing photonic chips that leverage light for data processing and communication, significantly enhancing the speed and efficiency of artificial intelligence computations. By utilizing integrated optical technology, the company designs processors that accelerate key operations in neural networks through programmable photonic elements, which are fabricated alongside traditional transistors. This innovative approach allows for improved performance in applications such as image recognition and natural language processing while maintaining low power consumption. Lightmatter's technology primarily serves sectors including artificial intelligence, cloud computing, and telecommunications, positioning the company as a leader in light-based computing solutions.

AMP

Series C in 2023
AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

Clever Care Health Plan

Series C in 2023
Clever Care Health Plan, Inc. is a healthcare insurance provider that specializes in Medicare Advantage plans, integrating the principles of Eastern and Western medicine. Founded in 2018 and headquartered in Westminster, California, with an additional office in Arcadia, the company offers a range of culturally sensitive healthcare solutions. Its plans include access to services such as acupuncture, herbal remedies, tai chi, and cupping, aimed at enhancing both physical and mental well-being. Clever Care connects its members with diverse networks of hospitals and healthcare providers who are attuned to their cultural needs and language preferences. The company distributes its products through brokers and sales agents, ensuring that Medicare beneficiaries receive the support and services they require.

Mill

Venture Round in 2023
Mill is a company focused on addressing food waste, a significant environmental challenge. It offers innovative kitchen bins that dry, shrink, and eliminate odors from leftover food, transforming waste into a compost-like material. These digitally connected bins can be rented, allowing users to efficiently manage their kitchen waste overnight. Additionally, Mill facilitates the shipping of the processed material to facilities that convert it into animal feed, thereby promoting a sustainable waste management system. Through its products and services, Mill aims to contribute to a healthier environment by providing practical solutions for reducing food waste at home.

Chronosphere

Venture Round in 2023
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Carrick Therapeutics

Series C in 2022
Carrick Therapeutics, Ltd., established in 2015 and headquartered in Dublin, Ireland, focuses on developing innovative cancer therapeutics aimed at transforming cancer treatment. The company targets molecular pathways associated with aggressive and resistant forms of cancer, employing advanced mechanisms to improve treatment outcomes. By enabling the detection of predictive biomarkers, Carrick Therapeutics facilitates the initiation of targeted therapies at early stages, ultimately striving to enhance the lives of cancer patients.

AMP

Series C in 2022
AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

Kindbody

Venture Round in 2022
Kindbody is a fertility clinic network and family-building benefits provider that offers a comprehensive range of services aimed at supporting individuals and couples in their journey to parenthood. The company's offerings include fertility assessments, preservation, genetic testing, in vitro fertilization (IVF), as well as donor, surrogacy, and adoption services. Employers collaborate with Kindbody to provide their employees with essential financial, medical, and emotional support throughout the family-building process. Kindbody serves over 100 employers, impacting more than 2.4 million lives, while also delivering fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. The organization emphasizes improving access to holistic health and fertility services for women at affordable rates, utilizing modern technology to enhance the patient experience.

Medallion

Series C in 2022
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

Gametime

Venture Round in 2022
Gametime is a mobile platform that specializes in selling last-minute tickets for a variety of live events, including sports, concerts, and theater, across the United States and Canada. The service simplifies the ticket purchasing process by curating a selection of the best available options from over 10,000 seats, allowing clients to choose from 50 top values. Each ticket option is accompanied by a high-resolution panoramic photo, providing users with a preview of the view from their chosen section. The platform features interactive seat maps that allow for easy comparison of prices and locations, enhancing the customer experience. Tickets are conveniently delivered directly to the user's phone, facilitating instant access to entertainment.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. develops cloud infrastructure and data center security solutions, focusing on cybersecurity and artificial intelligence to address cyber threats in hybrid-cloud environments. The company provides a platform that enables threat detection, breach remediation, and security hardening specifically for business-critical software as a service (SaaS) applications. By delivering cloud detection and response capabilities, Obsidian Security aims to enhance the security posture of enterprises. Founded in 2017 and headquartered in Newport Beach, California, the company is dedicated to creating a comprehensive understanding of interconnected applications to ensure their safety and security.

Brightline

Series C in 2022
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Digits

Series C in 2022
Digits is a fintech company building tools for businesses and finance professionals by leveraging its proprietary Living Model technology. The company was founded by Wayne Chang and Jeff Seibert in 2018 and is headquartered in San Francisco, California, United States.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Genesis Global

Series C in 2022
Genesis Global enables financial markets organizations to innovate at speed through a software application development platform, prepackaged solutions and deep expertise in capital markets and financial services. In supercharging developers to rapidly deliver high-performance, resilient and secure applications, Genesis replaces the buy vs. build challenge with a buy-to-build solution. The Genesis platform is designed with flexibility and performance at its core, providing developers with the frameworks, integrations and components required to automate manual workflows, enhance legacy systems and build entirely new applications. Featuring a resilient, real-time service-oriented architecture, Genesis excels across the performance envelope of low-latency, high-throughput and high-scalability, powering mission-critical applications at the world’s leading financial institutions. Strategically backed by Bank of America, BNY Mellon and Citi, Genesis Global has offices in Miami, New York, Charlotte, London, Leeds, São Paulo, Dublin and Bengaluru.

Homebound

Series C in 2022
Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human. Born out of the 2017 Northern California wildfires, Homebound was created by a local team of construction, real estate, design and technology experts who set out to create a better homebuilding solution for friends, family and neighbors affected. Homebound is the first homebuilder to manage the entire building process for homeowners and support them every step of the way — from insurance negotiation and architecture all the way to permitting, construction and move-in. Through easy-to-use technology and a network of vetted building experts, Homebound is simplifying the rebuilding process and alleviating the stress, complexity and uncertainty homeowners face after a natural disaster.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing novel small molecule medicines aimed at treating autoimmune diseases, inflammatory diseases, and cancer by targeting the innate immune system. The company employs a structural immunology platform that provides deep insights into the mechanisms and molecular structures involved in immune responses. This platform integrates proprietary protein engineering capabilities with advanced rational and structure-based drug design tools, allowing for precise targeting of the innate immune system. Ventus is actively building a pipeline of drug programs that address critical targets within this system, particularly proteins involved in inflammasome and nucleic acid-sensing signaling pathways, thereby enabling the treatment of both acute and chronic inflammatory and immune-related conditions.

Pecan

Series C in 2022
Pecan operates a predictive analytics platform that empowers businesses to forecast critical outcomes effectively. It utilizes a low-code interface that simplifies the predictive modeling process, allowing companies to generate accurate predictions without needing in-house data scientists or engineers. Pecan automates data preparation and feature engineering, enabling users, particularly SQL-trained business intelligence analysts, to create tailored predictive models quickly. The platform supports various industries, including fintech, insurance, retail, and consumer services, by providing pre-built models and templates that align with specific business objectives. This capability allows organizations to enhance customer lifetime value, retention, conversion rates, and demand forecasting. Pecan's solutions have a significant financial impact, influencing billions of dollars in revenue across various sectors.

mabl

Series C in 2021
Mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, founded in 2016. It offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. The platform provides scriptless testing and integrates seamlessly into the continuous integration and continuous deployment (CI/CD) development lifecycle, allowing software teams to create and maintain reliable, auto-healing tests. By streamlining the testing process, Mabl enables organizations to enhance the speed and quality of their software releases, facilitating faster delivery of high-quality applications while helping developers and testers address bugs before they reach production.

Yellowbrick Data

Series C in 2021
Yellowbrick Data was founded in 2014 by experts in database and flash memory technologies to simplify data warehousing. They wanted to solve the challenges of high availability, running complex mixed workloads, support for ad-hoc SQL, computing correct answers on any schema, massive scalability and supporting large numbers of concurrent users. Yellowbrick Data empowers companies to make faster decisions with all of their data. Built for enterprises and the hybrid cloud, the Yellowbrick Data Warehouse deploys powerful analytics anywhere, with best-in-class economics.

Multiverse

Series C in 2021
Multiverse is an EdTech startup focused on providing an alternative to traditional university education through career-oriented apprenticeships. By matching young talent with professional services and digital roles, Multiverse aims to deliver relevant skills and applied learning experiences. The platform not only equips individuals with necessary competencies but also fosters the development of social capital and professional networks, empowering them to shape their own career paths. This approach offers a viable alternative to conventional university routes and standard corporate training programs, catering to the evolving needs of the workforce.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.

Snorkel AI

Series C in 2021
Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

Neuralink

Series C in 2021
Neuralink is focused on developing implantable brain-machine interfaces aimed at assisting individuals with paralysis and addressing neurological conditions. The company is dedicated to creating high-bandwidth devices that not only facilitate treatment and diagnosis but also have the potential to enhance cognitive abilities. By innovating in this field, Neuralink seeks to enable medical professionals to effectively manage serious brain diseases while expanding the capabilities of individuals within the community.

TMRW Life Sciences

Series C in 2021
TMRW Life Sciences is a technology company focused on improving standards of safety, transparency, and accountability in the management of frozen eggs and embryos within the IVF sector. The company has developed the first automated cryo-management platform specifically designed for this purpose, which integrates a digital chain of custody with robotic storage and monitoring solutions. This innovative approach aims to replace traditional manual methods that have remained largely unchanged over the years, thereby significantly reducing the risk of errors that could have serious consequences. Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW combines expertise in fertility, embryology, cryo-management, automation, software development, and robotics to enhance the specimen management process for clinics, facilitating advancements in IVF technology. The company is headquartered in New York, New York.

Resolution Games

Series C in 2021
Resolution Games is a gaming studio specializing in the development of virtual reality (VR) and augmented reality (AR) experiences. Led by industry experts, the studio aims to create immersive video games that cater to a diverse range of gamers. By focusing on delivering rich and engaging worlds, Resolution Games enables players to fully enjoy the enhanced sense of presence that VR and AR technologies offer. The company's titles are designed for multiple platforms, ensuring accessibility for a broad audience of gaming enthusiasts.

Instawork

Series C in 2021
Instawork is a career marketplace that connects hospitality businesses with qualified professionals seeking flexible job opportunities. Founded in 2015 and headquartered in San Francisco, California, the company transforms traditional recruiting by offering an automated matching solution that allows businesses to quickly find suitable hourly workers for on-demand shifts. By streamlining the hiring process, Instawork aims to create economic opportunities for local businesses and professionals, enhancing workforce accessibility in the hospitality sector.

Kindbody

Series C in 2021
Kindbody is a fertility clinic network and family-building benefits provider that offers a comprehensive range of services aimed at supporting individuals and couples in their journey to parenthood. The company's offerings include fertility assessments, preservation, genetic testing, in vitro fertilization (IVF), as well as donor, surrogacy, and adoption services. Employers collaborate with Kindbody to provide their employees with essential financial, medical, and emotional support throughout the family-building process. Kindbody serves over 100 employers, impacting more than 2.4 million lives, while also delivering fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. The organization emphasizes improving access to holistic health and fertility services for women at affordable rates, utilizing modern technology to enhance the patient experience.

Sense

Series C in 2021
Sense is a smart talent engagement and communication platform built for the staffing industry. It helps reduce turnover, increases re-deployment rates, and gives a real-time 360 view of the pulse of consultants. Founded in 2016, the company is headquartered in San Francisco, California.

Ribon Therapeutics

Series C in 2021
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing novel cancer therapies that target monoPARP proteins, which are essential regulators of cancer survival mechanisms. Established in 2015, Ribon is leveraging insights from its scientific founders and an experienced management team to create a proprietary drug discovery platform aimed at understanding the molecular actions and biological functions of monoPARPs. This platform enables the development of small molecule inhibitors designed to disrupt cancer cells' abilities to withstand stress, potentially leading to innovative treatments for cancer and other diseases. The company is supported by notable life science investors, positioning it for growth in the biopharmaceutical sector.

Lovevery

Series C in 2021
Lovevery, Inc. is a company based in Boise, Idaho, that specializes in manufacturing educational play products for babies and young children. Founded in 2015, Lovevery offers a range of toys designed by child development experts to support stage-based learning. Their flagship product, the Play Gym, includes various accessories such as a ball, batting ring, and teething rings, tailored to stimulate a child's senses and encourage developmental milestones. In addition to physical products, Lovevery provides parents with stage-based information and resources to enhance their children's learning experiences. The company has received recognition for its innovative offerings through awards from notable publications and organizations. Lovevery's products are available for purchase online, and the company has garnered support from several prominent investors.

Clear Labs

Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Bowery Farming

Series C in 2021
Bowery Farming Inc. is a modern farming company based in New York that specializes in post-organic produce, offering products such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery aims to revolutionize agriculture by using technology to create ideal indoor farming conditions. Its proprietary software, BoweryOS, integrates vision systems, automation, and machine learning to monitor and optimize plant growth continuously. This controlled environment allows Bowery to produce food using zero pesticides and 95% less water, achieving over 100 times the productivity of traditional farming on the same land footprint. Bowery's produce is available in select grocery stores, including Whole Foods and Foragers, and is featured on the menus of renowned restaurants in New York.

Tend

Series C in 2021
Tend is a modern dental care provider that aims to transform the patient experience by offering personalized and hassle-free services. Launched in October 2019, the company has established 25 locations across major cities including New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on patient happiness in a calm and inviting environment, leveraging technology and a hospitality-driven approach alongside a highly skilled clinical team. By prioritizing comfort and efficiency, Tend has become one of the top-rated full-service dental practices in the country, employing over 650 team members to support its mission of delivering quality oral health care.

Cameo

Series C in 2021
Cameo is a marketplace that enables fans to book personalized video shoutouts from a diverse range of talent, including celebrities and influencers. The company aims to create authentic and personalized fan experiences by providing a platform where users can easily connect with their favorite personalities. Customers can browse through thousands of available talents and pay for customized video messages, allowing them to share unique experiences with friends and loved ones.

insitro

Series C in 2021
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Monte Rosa Therapeutics

Series C in 2021
Monte Rosa Therapeutics is a biotechnology company focused on developing innovative cancer therapeutics that utilize molecular glue degraders (MGDs) to modulate protein degradation pathways. By leveraging the body's natural mechanisms for protein destruction, these small molecule drugs selectively target and degrade disease-causing proteins. The company employs its QuEEN platform, which combines artificial intelligence and proprietary experimental tools, to identify relevant proteins for degradation. With a diverse library of over 50,000 MGD molecules, Monte Rosa's lead candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing promise for treating MYC-driven tumors. The company aims to advance its pipeline of pioneering therapies for cancer and other diseases.

Tenaya Therapeutics

Series C in 2021
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease. The company's therapies address heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration, enabling physicians to regenerate heart tissue, and additional programs focused on cardiomyopathies.

Nanit

Series C in 2021
Nanit team is a tight-knit collection of scientists, parents and designers—experts in the first beautiful months of human life. They have developed advanced computer vision and machine learning algorithms to help us measure human behavior. They use this knowledge and technology to create innovative products that are safer and smarter, for parents and babies everywhere. Their team comes from great companies like Applied Materials, Diapers.com, Philips, Time Warner and Tiny Love, where they've focused on building brands and products people love.

Evox Therapeutics

Series C in 2021
Evox Therapeutics is a biotechnology company based in Oxford, United Kingdom, founded in 2016. The company specializes in developing exosome-based therapeutics aimed at treating rare and severe diseases. By harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, Evox focuses on creating innovative drug delivery systems that utilize nucleic acids and proteins. This technology allows for targeted delivery to specific organs, including the brain and central nervous system, addressing limitations often encountered with traditional therapies. Evox's proprietary methods for modifying exosomes enhance their ability to transport therapeutic agents effectively, thereby improving treatment options for patients with limited alternatives. The company is supported by a strong intellectual property portfolio and investments from leading life sciences venture capital groups, positioning it as a leader in the emerging field of exosome-based therapeutics.

TScan Therapeutics

Series C in 2021
TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Vera Therapeutics

Series C in 2021
Vera Therapeutics, a biotechnology company based in South San Francisco, California, specializes in developing innovative biologic therapeutics aimed at treating serious immunological diseases and genetic disorders. Founded in 2016 and renamed in March 2020, the company's research focuses on transformative treatments that can significantly improve patient outcomes. One of its key product candidates is atacicept, a fusion protein designed for self-administration via a weekly subcutaneous injection. Atacicept works by inhibiting both B lymphocyte stimulator and a proliferation-inducing ligand, which are involved in the production of autoantibodies that contribute to various autoimmune diseases. Additionally, Vera Therapeutics is exploring gene-editing technologies that hold the potential to address conditions such as sickle cell disease and cystic fibrosis.

FogPharma

Venture Round in 2021
FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.

Encodia

Series C in 2020
Encodia, Inc., founded in 2015 and headquartered in San Diego, California, specializes in proteomics research and the development of innovative protein analysis technology. The company offers a platform that utilizes reverse-translation technology to convert peptide sequence information into DNA libraries, facilitating scalable and efficient protein sequencing. This capability enables researchers to analyze protein samples comprehensively, thereby advancing the field of personalized medicine. By democratizing access to detailed information on cellular processes, Encodia aims to accelerate the discovery of novel approaches to addressing challenging diseases.

Flock Freight

Series C in 2020
Flock Freight is reimagining and reinventing the freight industry by relentlessly eliminating inefficiency and waste through algorithmic pooling. Working at the intersection of cutting-edge technology and human-centric logistics management, Flock Freight tailors its shipping experience to meet your business’s needs. Flock Freight seamlessly pools any freight to find the perfect route, avoiding terminals and risky offloads so that a shipment travels safely and directly to its destination, damage-free. The result: on-time delivery with every shipment—guaranteed. With venture capital from Google Ventures and SignalFire, Flock Freight is one of the largest startups in San Diego, California. The company's team is obsessed with aggressively growing its customer base, constantly improving the technology platform, and delivering a superior customer experience. Flock Freight aims to fundamentally change the $60 billion LTL freight industry across North America with FlockDirect—one pooled shipment at a time.

Weaveworks

Venture Round in 2020
Weaveworks Limited is a software company founded in 2014 and based in London, with an additional office in San Francisco. The company specializes in open-source software that facilitates the management of Docker containers and Kubernetes workloads, providing tools for developers and DevOps teams. Its products include Weave Net, which offers a portable software-defined networking solution; Weave Scope, enabling real-time visualization and interaction with distributed applications; Weave Flux, which automates the routing of requests for containerized microservices; and Weave Cloud, a Software-as-a-Service platform that helps teams connect, monitor, and deploy cloud-native applications. Weaveworks aims to simplify the complexities of operating cloud-native applications by offering automated continuous delivery pipelines, observability, and monitoring, while also contributing to various open-source projects.

Ready

Series C in 2020
Ready Responders was founded in 2016 with the mission of giving patients direct access to healthcare professionals in their homes and giving Responders the opportunity to provide care in their communities. Responders travel to patients’ homes to address their physical, mental, and social health needs, utilizing technology to connect with an advanced medical or behavioral health provider, and connecting them with external resources and relationships for ongoing, sustained support. With Ready Responders, patients now have access to quality whole-person care in their homes, 16 hours a day, 365 days a year, and talented individuals are provided the opportunity to work with a rapidly growing, mission-driven company. They are in-network with most major insurance companies in the markets they serve. Ready Responders is backed by leading venture capital firms, including Google Ventures, Founders Fund, Rise of the Rest, and City Lights Capital.

Lambda School

Series C in 2020
Lambda School is a combination of a school and an investment fund. Lambda School's mission is to find untapped or underutilized talent, and train that talent for the most in-demand jobs in the world. Lambda School is pioneering a new model of higher education in which the school invests in the students, instead of the other way around.

UJET

Series C in 2020
UJET, Inc. specializes in developing customer support software and platform solutions that enhance customer communications. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, the company offers a cloud contact center platform that integrates seamlessly with major customer relationship management systems like Salesforce, Zendesk, and Kustomer. UJET's platform is designed for the smartphone era, modernizing digital and in-app customer experiences while eliminating the need for customers to switch between different communication channels. By utilizing multiple voices, online messaging, and mobile features, UJET assists customer service agents in managing incoming calls and resolving issues efficiently. The incorporation of artificial intelligence across its services further automates processes and improves interaction quality. Additionally, UJET provides a wait time messaging tool that offers live updates to customers while they are on hold, enhancing overall service satisfaction.

PatientPing

Series C in 2020
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Scandit

Series C in 2020
Scandit AG is a technology company based in Zurich, Switzerland, specializing in mobile computer vision and augmented reality solutions for enterprises. Founded in 2009, Scandit develops barcode scanning software that enhances scanning performance across various devices, including smartphones, tablets, and wearables. Its offerings include the Scandit Keyboard Wedge, Barcode Scanner SDK for the Web, and MatrixScan, which improve processes in retail, logistics, healthcare, and manufacturing. The company's solutions enable functionalities such as mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating contactless interactions. Scandit's products are utilized by notable clients such as 7-Eleven, Carrefour, and Johns Hopkins Hospital. By leveraging proprietary technology in computer vision and machine learning, Scandit aims to streamline operations, reduce costs, and enhance customer experiences across multiple industries. The company also maintains offices in San Francisco, Boston, London, and Warsaw.

Aledade

Series C in 2020
Aledade, Inc. is a health technology company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and based in Bethesda, Maryland, Aledade partners with independent primary care providers to offer a comprehensive suite of services, including data analytics, guided workflows, regulatory expertise, and payer relationships. The company also provides 360° practice support, workflow optimization, and assistance with ACO governance and contracting. By leveraging its technology platform, Aledade enables physicians to access integrated data and insights that help improve patient care, reduce costs, and maintain the autonomy of independent practices. Its tailored solutions cater to a diverse range of healthcare providers, including small practices, large practices, community health centers, and multispecialty groups.

Podium

Series C in 2020
Podium, Inc. is a software company based in Provo, Utah, that provides a customer communication platform designed to help businesses manage online reviews and enhance customer interactions at a local level. Founded in 2013, the platform allows users to collect and respond to reviews from various sites such as Google and Facebook, right at the moment of transaction. It offers features for interaction management, enabling businesses to communicate effectively with leads, customers, and team members through messaging. Podium's system aggregates and analyzes customer reviews, helping organizations improve their online reputation, gain insights into customer preferences, and influence purchase decisions through user-generated content.

Element Science

Series C in 2020
Element Science is a medical device and digital health company that develops solutions at the intersection of clinical-grade wearable devices, machine learning algorithms, and lifesaving therapies to address the needs of high-risk cardiovascular patients, primarily as they transition from the hospital to home. The company developing a proprietary next-generation wearable digital platform that unites patient-centric human factor engineering, sophisticated machine learning algorithm development principles, and rigorous electromechanical medical device development standards. The company was founded in 2011 and is headquartered in San Francisco, California.

SambaNova Systems

Series C in 2020
SambaNova Systems, based in Palo Alto, California, develops a technology platform that integrates hardware and software solutions for artificial intelligence and machine learning applications. Founded in 2017, the company focuses on creating systems optimized for data processing, model training, and analytics, enabling high-performance execution of machine learning tasks. SambaNova's technology is designed to be flexible and scalable, catering to various sectors such as healthcare, finance, and autonomous vehicles. By enhancing the efficiency of AI-powered algorithms, SambaNova aims to support organizations in leveraging advanced data analytics effectively.

PACT Pharma

Series C in 2020
PACT Pharma, Inc. is a biotechnology company focused on developing personalized cell-based therapies for cancer treatment, specifically through neoantigen-specific adoptive T-cell therapies aimed at solid tumors. The company utilizes bioinformatics to analyze the DNA and RNA of patients' tumors and normal tissues, identifying candidate neoantigen peptides that can stimulate targeted antitumor T-cell responses. By recognizing unique neo-epitopes associated with individual cancers, PACT Pharma enables the engineering of autologous T cells designed to specifically target and eliminate tumor cells expressing these neoantigens. Founded in 2016 and based in South San Francisco, California, PACT Pharma is dedicated to advancing innovative treatment options for patients with cancer.

Digit

Series C in 2019
Digit is a finance app that analyzes your spending habits and automatically saves the perfect amount every day. The platform automates the day-to-day work of managing money so you don’t have to think about it. They help eliminate the stress and anxiety people feel about their finances while helping them build a proven foundation for the future they’re trying to achieve. Digit keeps your money socked away in a separate account and your savings will depend on a number of variables, including how much money you keep in your checking account and what your saving and spending pattern. Their technology combines machine learning and behavioral psychology to provide a financial assistant you can trust to work toward your goals while you spend your time and effort on what’s most meaningful in your life. It saves the amount of money every day based on your spending and income and tells you the intelligent timeline for achieving them. Digit was founded in 2013 and is headquartered in San Francisco, California, United States.

Ethos Life

Series C in 2019
Ethos Life is an insurance company that provides modern and ethical life insurance to protect life. They’re building ground-breaking software for life insurance (a $650 billion market) and the company's mission is to make protecting your family affordable, accessible, and instant. It also employs a human approach in delivering its services. Ethos policies are issued and guaranteed by Legal & General America (LGA), a large U.S. life insurance provider since 1836. They use technology to learn about what makes you unique so that they can find new and truly personal ways to cover you. Ethos was founded in 2016, the company is headquartered in San Francisco, California, United States.

Incorta

Series C in 2019
Incorta, Inc. is a data analytics company based in San Mateo, California, founded in 2013. It offers a unified platform designed to tackle complex data analytics challenges for enterprises, enabling them to be more agile and competitive. The company's Direct Data Platform allows organizations to acquire, enrich, analyze, and act on their business data efficiently. This platform features a direct data mapping engine that enhances query performance, eliminates costly join operations, and significantly reduces the time needed to deploy new analytics applications. Incorta serves a diverse range of clients, including notable brands and organizations, providing solutions for real-time operational analytics, embedded analytics, and comprehensive dashboards tailored for various business environments. The company is supported by several prominent venture capital firms and collaborates with customers ranging from Fortune 5 to Global 2000 companies.

Cockroach Labs

Series C in 2019
Cockroach Labs, Inc. is a developer of open-source database software, primarily known for its distributed SQL database, CockroachDB. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a cloud-native platform designed for modern application development. CockroachDB allows organizations to build scalable applications that can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, with minimal disruption and no manual intervention. The database supports strongly consistent ACID transactions and offers an SQL API for data manipulation and querying. Its software is utilized by a diverse range of customers, from startups to Fortune 500 companies, across various industries, providing enterprise-grade disaster recovery services and enabling rapid development without compromising on consistency.

Helium

Series C in 2019
Helium is an internet-of-things developer platform for building the network and transferring IoT device data. The platform builds the peer-to-peer wireless network to simplify connecting anything to the internet by rewarding anyone to become a network operator. It provides wireless coverage for low-power Internet of Things (IoT) devices and earns a new cryptocurrency, Helium, from your living room. Helium tokens by verifying network transactions, adding new blocks to the blockchain, and performing other tasks. The Proof-of-Coverage is a unique work algorithm that uses radio waves to validate that hotspots are providing legitimate wireless coverage.

Yellowbrick Data

Series C in 2019
Yellowbrick Data was founded in 2014 by experts in database and flash memory technologies to simplify data warehousing. They wanted to solve the challenges of high availability, running complex mixed workloads, support for ad-hoc SQL, computing correct answers on any schema, massive scalability and supporting large numbers of concurrent users. Yellowbrick Data empowers companies to make faster decisions with all of their data. Built for enterprises and the hybrid cloud, the Yellowbrick Data Warehouse deploys powerful analytics anywhere, with best-in-class economics.

YellowBrick

Series C in 2019
Yellowbrick Learning, Inc. operates an online platform designed to facilitate career exploration and development for individuals interested in creative industries such as fashion, sports, beauty, music, and media. Founded in 2013 and based in New York, the company partners with leading universities, brands, and employers to create educational experiences that help students build relevant skills and gain industry insights. By focusing on the alignment of personal passions with career opportunities, Yellowbrick aims to empower the next generation of talent to identify, pursue, and advance their careers within the creative arts and entertainment sectors.

Copper

Series C in 2019
Copper is an AI-first CRM that eliminates data entry, automates sales processes and optimizes the entire customer journey to grow sales. Investors include Norwest Venture Partners (Promod Haque, Midas List Hall of Fame Investor), True Ventures (Phil Black, Co-Founder), GV (Formerly Google Ventures), Texas Pacific Group, Bloomberg Beta, Investment Group of Santa Barbara, Next World Capital, Brad Jones (Redpoint Ventures), Industry Ventures, Crunchfund and Danhua Capital.

Cala Health

Series C in 2019
Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.

Acalvio

Series C in 2019
Acalvio specializes in cyber deception technology, providing enterprises with tools to defend against advanced security threats. Its flagship product, the Acalvio ShadowPlex Cyber Deception Platform, leverages 25 patents in autonomous deception and advanced AI to enhance security measures. The platform offers solutions for Identity Threat Detection and Response, Advanced Threat Detection, Operational Technology Security, Zero Trust frameworks, Active Directory Protection, and Ransomware Protection. Based in Silicon Valley, Acalvio caters to Fortune 500 companies and government agencies, with deployment options available on-premises, in the cloud, or through managed service providers. The technology is designed to reduce attacker dwell time by enabling early detection of threats and improving security operations center efficiency through enhanced investigation and threat-hunting capabilities. This approach helps organizations achieve better defense in depth, minimize false positives, and obtain actionable intelligence for effective remediation.

HOVER

Series C in 2019
HOVER Inc. is a technology company based in San Francisco, California, that specializes in home measurement applications that create interactive 3D models of properties. Founded in 2011, the company leverages computer vision and 3D mapping technology to assist homeowners, contractors, and insurance professionals. Its platform enables users to generate accurate property models quickly using just a few photos taken with a smartphone, facilitating project estimation and visualization. This technology aids exterior contractors in obtaining precise measurements, assists insurance markets in creating estimates and processing claims, and helps homeowners visualize final project outcomes. HOVER's innovative approach has made the home improvement process more transparent and engaging. The company has formed a strategic partnership with SRS Distribution Inc. to enhance its service offerings.

FullStory

Series C in 2019
FullStory, Inc. is a company that provides an online application designed to capture and analyze customer experience data on a single platform. Its technology enables pixel-perfect session playback, automatic insights, funnel analytics, and robust search and segmentation. This functionality empowers product managers, designers, developers, and support agents to enhance online experiences for customers. Founded in 2014 and headquartered in Atlanta, Georgia, FullStory was previously known as Monetology, LLC before changing its name in June 2015. The company has also established a strategic partnership with Digital Yalo to further its mission of improving customer interactions.

Lola.com

Series C in 2019
Lola.com is an easy-to-use travel management tool that helps companies book, report, and save on business travel. Life becomes simpler with employee friendly business travel policies, fun travel tracking tools, and transparent spend reporting for business travel managers. For the business travelers, it enables easy flight and hotel booking, team destination sharing, loyalty points from the actual hotels and airlines, and 24/7 agent support. Its book on behalf feature lets executive assistants, easily book travel like a boss. Founded on 2015, Lola.com works for both employers and employees. It is headquartered in Boston, Massachusetts.

Managed by Q

Series C in 2019
Managed by Q Inc. operates a workplace management platform that facilitates the efficient operation of offices. The company provides a comprehensive suite of services, including cleaning, maintenance, IT support, and security, alongside workplace staffing and project management services. Its technology platform connects businesses to essential services for managing their workspaces, enabling tasks such as cleaning schedules, supply replenishment, and maintenance through an intuitive application. Founded in 2013 and based in New York, the company also emphasizes economic empowerment by creating jobs for its operators and supporting small businesses. As a subsidiary of Eden Technologies, Inc., Managed by Q is active in major cities including New York, Los Angeles, Chicago, and San Francisco, aiming to redefine office management and enhance workplace productivity.

Relay Therapeutics

Series C in 2018
Relay Therapeutics is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process, particularly in targeted oncology. Utilizing its innovative Dynamo platform, the company combines advanced computational techniques with experimental methods to enhance small molecule therapeutic discovery. Relay Therapeutics is developing several product candidates, including RLY-1971, an oral inhibitor targeting the SHP2 protein, currently in Phase 1 trials for advanced solid tumors; RLY-4008, a selective inhibitor for patients with FGFR2 alterations; and RLY-PI3K1047, aimed at cancer-associated mutations of the PI3K alpha protein. Founded in 2015, Relay Therapeutics is dedicated to addressing complex diseases through its unique approach to drug discovery.

CyberGRX

Series C in 2018
CyberGRX provides the most comprehensive third-party cyber risk management platform to cost-effectively identify, assess, mitigate and monitor an enterprise’s risk exposure across its entire partner ecosystem. Through automation and advanced analytics, the CyberGRX solution enables enterprises to collaboratively mitigate threats presented from their increasing interdependency on vendors, partners and customers. CyberGRX is based in Denver, CO. For more information, visit www.cybergrx.com or follow @CyberGRX on Twitter.

Benson Hill

Series C in 2018
Benson Hill is a crop improvement company that unlocks the natural diversity of plants and empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable food and ingredients. Benson Hill empowers innovators to develop more healthy, flavorful, and sustainable food by unlocking the natural genetic diversity of plants. Benson Hill’s CropOS™ platform combines machine learning and big data with breeding techniques and plant biology to drastically accelerate and simplify the product development process.

Cambridge Epigenetix

Series C in 2018
Cambridge Epigenetix aims to change the way medicine is practiced by reducing several routine and important diagnostic screening and detection tests for colorectal cancer and other common tumours to a simple blood draw. CEGX is pioneering the field of clinical epigenetics, and the company’s technology has proven the link between the epigenetic DNA modification 5-hydroxymethylcytosine (5hmC) and disease. Research has revealed a wide range of diagnostic and prognostic applications for 5hmC, now one of the most important biomarkers in the quest to improve human health. Spun-out of the University of Cambridge in 2012, CEGX was founded to develop and commercialise the science of world leading researchers Professor Sir Shankar Balasubramanian, co-inventor of Solexa sequencing, and Professor Anjana Rao, who identified the essential role of the TET enzymes and 5hmC in development and disease. A privately held company headquartered in Cambridge, UK, Cambridge Epigenetix is supported by several high-profile investors: GV (Google Ventures), Sequoia, Syncona, New Science Ventures, Ahren Innovation Capital, DNA Capital and the University of Cambridge.

SQZ Biotech

Series C in 2018
SQZ Biotech is a clinical-stage biotechnology company focused on developing innovative cell therapies for patients facing cancer, infectious diseases, and other serious health conditions. Utilizing its proprietary CellSqueeze technology, SQZ Biotech can deliver a variety of materials into diverse patient cell types, enabling the engineering of therapies that address a wide array of clinical challenges. The company aims to create well-tolerated cell therapies that not only enhance therapeutic benefits but also improve the overall patient experience compared to traditional cell therapy methods. Through a combination of internal research initiatives and external collaborations, SQZ Biotech is advancing a new generation of cellular therapies aimed at both immune activation and immune suppression.

Yesware

Series C in 2018
Yesware, Inc. is a company that creates a prescriptive sales platform aimed at enhancing the productivity of sales professionals and startups globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within popular email clients like Outlook and Gmail. The platform allows users to track emails, schedule messages, set reminders, and make calls directly from their inboxes. It also features customizable email templates and analytics to help sales teams monitor performance and identify effective strategies. With over 1.2 million installations, Yesware serves a diverse clientele, from small businesses to large enterprises, including notable organizations like Yelp and Twitter. The company is focused on improving customer interactions and streamlining sales processes to deliver better buying experiences.

Brandless

Series C in 2018
Brandless, Inc. is an online consumer commerce platform based in San Francisco, California, that offers a diverse range of products across several categories. Founded in 2015, the company sells food items such as snacks, granola, and baby food, as well as home essentials including cleaning supplies, tableware, and office products. Additionally, Brandless provides beauty and personal care items, health and wellness products like vitamins and supplements, baby products, and pet supplies. The company aims to create a marketplace that empowers consumers to make healthier and more sustainable choices for themselves, their families, and the environment by prioritizing quality and collaboration.

Verana Health

Series C in 2018
Verana Health, Inc. is a digital health company based in San Francisco, California, that specializes in transforming healthcare data into actionable insights. Founded in 2008 and formerly known as Digisight Technologies, the company connects healthcare providers with patients through innovative solutions. Its flagship product, SightBook, is a mobile application that enables users to test their vision and share results with their physicians in real-time, facilitating timely appointments and treatments. Verana Health manages data from over 20,000 healthcare providers and 70 electronic health record systems, leveraging its AI-enhanced platform, VeraQ™, to create a robust healthcare data ecosystem. By utilizing advanced analytics on curated datasets, Verana Health supports life sciences partners in improving clinical research and enhancing patient care outcomes.

Lime

Series C in 2018
Lime is a transportation company that focuses on providing sustainable solutions for urban mobility by offering electric scooters and bike-sharing services. The company partners with cities to deploy a fleet of electric bikes and scooters equipped with GPS and self-activating locks, which allows users to access affordable and reliable transportation options. Lime aims to address the first- and last-mile transportation challenges, promoting environmentally friendly alternatives that help reduce carbon footprints. By encouraging a shift in transportation behavior, Lime seeks to empower future generations to contribute to a more sustainable planet.

Decibel Therapeutics

Series C in 2018
Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.

Amino Apps

Series C in 2018
Amino Apps enables people to discover, develop, and express their interests and passions. Founded in 2011, Amino Apps offer a network of communities allowing its users explore and obsess over the things they're into.

Rocketrip

Series C in 2018
Rocketrip, Inc. is a travel management platform that incentivizes employees to make cost-effective travel decisions for business purposes. Founded in 2013 and based in New York, the platform provides real-time insights into travel expenses, helping employees understand reasonable spending limits. By establishing a custom-calibrated Price to Beat, Rocketrip motivates employees to select lower-cost options for flights, car rentals, and hotel accommodations, thereby enabling them to earn rewards for saving the company money. The platform integrates seamlessly with existing online booking processes, ensuring minimal disruption. Rocketrip is utilized by notable enterprises such as iHeartMedia, Feld Entertainment, and Twitter, and operates as a subsidiary of Mondee Holdings Inc.

Motive

Series C in 2018
Motive is a technology company building technology to improve the safety, productivity, sustainability, and profitability of businesses that power the physical economy. Combined with AI, the Motive platform gives you complete visibility and control and significantly reduces manual workloads by automating and simplifying tasks. Motive serves small businesses across a wide range of industries, including transportation and logistics, construction, energy, field service, manufacturing, agriculture, food and beverage, retail, and the public sector. Motive is a fully unified integrated operations platform, combining driver safety, fleet management, equipment monitoring, and spend management all in one place.

theSkimm

Series C in 2018
TheSkimm, Inc. is a digital media company founded in 2012 and based in New York, specializing in delivering concise and relevant information to educated professionals, particularly women. Its flagship product is a daily newsletter that breaks down news, trends, and policies impacting women's lives, allowing them to make informed decisions. TheSkimm aims to empower its audience by providing reliable, non-partisan content that integrates easily into daily routines. In addition to the Daily Skimm, the company's offerings include various newsletters such as Skimm Money, a podcast, and a mobile app. TheSkimm also operates Skimm Studios, which produces video and audio content, and SKM Lab, an in-house creative agency for brand engagement. Committed to social impact, theSkimm supports initiatives like Skimm Your Ballot to encourage voter participation and the #ShowUsYourLeave movement to promote transparency in paid family leave. Co-founded by Carly Zakin and Danielle Weisberg, theSkimm has developed a loyal audience and continues to innovate within the media landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.